Results 1 to 10 of about 129,163 (299)

Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis [PDF]

open access: yeseLife, 2019
Chronic itch remains a highly prevalent disorder with limited treatment options. Most chronic itch diseases are thought to be driven by both the nervous and immune systems, but the fundamental molecular and cellular interactions that trigger the ...
Carolyn M Walsh   +11 more
doaj   +3 more sources

Sex differences in itch perception and modulation by distraction--an FMRI pilot study in healthy volunteers.

open access: yesPLoS ONE, 2013
BackgroundEven though itch is a common syndrome of many diseases there is only little knowledge about sex and gender differences in pruritus, especially in central itch perception and modulation.
Astrid Stumpf   +7 more
doaj   +3 more sources

Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression

open access: yesMolecular Cancer, 2018
Background Circ-ITCH is a circRNA generated from several exons of itchy E3 ubiquitin protein ligase (ITCH) and tumor suppressor served as a sponge for certain miRNAs targeting their parental transcripts of ITCH.
Xiao Yang, Jie Han, Haiwei Yang
exaly   +3 more sources

Phase-Space Modeling and Control of Robots in the Screw Theory Framework Using Geometric Algebra

open access: yesMathematics, 2023
The following paper talks about the dynamic modeling and control of robot manipulators using Hamilton’s equations in the screw theory framework. The difference between the proposed work with diverse methods in the literature is the ease of obtaining the ...
Jesús Alfonso Medrano-Hermosillo   +3 more
doaj   +1 more source

Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis

open access: yesActa Dermato-Venereologica, 2023
Crisaborole, a phosphodiesterase 4 (PDE4) inhibitor, has been approved for the treatment of mild to moderate atopic dermatitis. Atopic dermatitis is often associated with increased pain.
Darya Pavlenko   +6 more
doaj   +1 more source

Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis [PDF]

open access: yes, 2018
Suppressor of Fused (SuFu), a tumour suppressor mutated in medulloblastoma, is a central player of Hh signalling, a pathway crucial for development and deregulated in cancer.
Alfonsi, Romina   +22 more
core   +17 more sources

Current and Emerging Therapies for Chronic Spontaneous Urticaria: A Narrative Review

open access: yesDermatology and Therapy, 2023
Chronic spontaneous urticaria (CSU) is a condition in which wheals, angioedema, and pruritus occur spontaneously and recurrently for at least 6 weeks. The etiology of this disease is partially dependent on production of autoantibodies that activate and ...
Gil Yosipovitch   +2 more
doaj   +1 more source

Exploration of sensory and spinal neurons expressing gastrin-releasing peptide in itch and pain related behaviors

open access: yesNature Communications, 2020
The role of gastrin related peptide (GRP+) neurons in itch is debated. Here, the authors generate a conditional knock-in mouse to label and manipulate GRP expressing DRG neurons and investigate their role in itch and nociception.
Devin M. Barry   +11 more
doaj   +1 more source

Predictive factors of quality of life in chronic pruritus patients: A cross-sectional studyCapsule Summary

open access: yesJAAD International, 2023
Background: Chronic pruritus severely impacts the quality of life (QoL) of patients. Due to its multifactorial nature, the presence of factors that can predict itch-specific QoL needs comprehensive exploration.
Siri Choragudi, BS   +2 more
doaj   +1 more source

Silencing E3 Ubiqutin ligase ITCH as a potential therapy to enhance chemotherapy efficacy in p53 mutant neuroblastoma cells [PDF]

open access: yes, 2020
P53 mutations are responsible for drug-resistance of tumour cells which impacts on the efficacy of treatment. Alternative tumour suppressor pathways need to be explored to treat p53- deficient tumours.
Hart, Stephen L   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy